BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 20, 2009
 |  BioCentury  |  Politics, Policy & Law

Closer to SBIR Turnaround

With last week's unanimous Senate vote to reauthorize the Small Business Innovation Research and Small Business Technology Transfer programs, the biotech industry is closer to winning a battle it has been waging for at least four years to reverse a Small Business Administration policy prohibiting SBIR grants to companies that are majority owned by VCs.

Unlike a House version of the reauthorization legislation, the Senate's SBIR/STTR Reauthorization Act of 2009 (S. 1233) would cap NIH awards to companies that are majority-owned by VCs at 18% of the agency's SBIR funds, while other agencies would...

Read the full 448 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >